Literature DB >> 8886002

Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).

K Maruyama1, T Tomita, K Shinozaki, H Kume, H Asada, T C Saido, S Ishiura, T Iwatsubo, K Obata.   

Abstract

In some pedigrees of familial Alzheimer's disease (FAD), three mutations of beta amyloid precursor protein (APP) have been found at the Val717 residue (to Ile, Phe, or Cly) and these mutations increase the secretion of A beta 42(43). To study the specificity of the effects of these mutations on APP processing, we transiently expressed APP genes with mutations of Val717 to Lys, Ser, Glu, or Cys in COS cells. The three familial AD-linked mutations increased the levels or ratios of A beta 42(43), whereas the secretion of A beta 40 was decreased. Other mutations irrelevant to FAD except Val717 to Lys had little effect on the ratio of A beta 42(43). Substitution to Lys decreased the secretion of A beta 42(43); substitution to Glu or Gly decreased the amount of intracellular C-terminal fragment produced by alpha-secretase, whereas it was increased by mutations to Phe, Cys, or Lys. However, the levels of secretion of soluble APP were constant, but a substitution to Glu reduced it. These results suggest a specific role of the Val717 residue in APP processing and, especially, in gamma-cleavage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8886002     DOI: 10.1006/bbrc.1996.1577

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  A notable cleavage: winding up with beta-amyloid.

Authors:  K S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein.

Authors:  S F Lichtenthaler; R Wang; H Grimm; S N Uljon; C L Masters; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain.

Authors:  Stefan F Lichtenthaler; Dirk Beher; Heike S Grimm; Rong Wang; Mark S Shearman; Colin L Masters; Konrad Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Familial Alzheimer's mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site.

Authors:  Wen Chen; Eric Gamache; David J Rosenman; Jian Xie; Maria M Lopez; Yue-Ming Li; Chunyu Wang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

5.  Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

Authors:  Omar Quintero-Monzon; Morgan M Martin; Marty A Fernandez; Christina A Cappello; Amanda J Krzysiak; Pamela Osenkowski; Michael S Wolfe
Journal:  Biochemistry       Date:  2011-09-30       Impact factor: 3.162

6.  Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Authors:  Vladimir Volloch; Bjorn Olsen; Sophia Rits
Journal:  Ann Integr Mol Med       Date:  2020

7.  Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.

Authors:  K Ancolio; C Dumanchin; H Barelli; J M Warter; A Brice; D Campion; T Frébourg; F Checler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis.

Authors:  Eric H Schroeter; Ma Xenia G Ilagan; Anne L Brunkan; Silva Hecimovic; Yue-ming Li; Min Xu; Huw D Lewis; Meera T Saxena; Bart De Strooper; Archie Coonrod; Taisuke Tomita; Takeshi Iwatsubo; Chad L Moore; Alison Goate; Michael S Wolfe; Mark Shearman; Raphael Kopan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

9.  Discovery of a novel pharmacological and structural class of gamma secretase modulators derived from the extract of Actaea racemosa.

Authors:  Mark A Findeis; Frank Schroeder; Timothy D McKee; Debra Yager; Patrick C Fraering; Steffen P Creaser; Wesley F Austin; Jon Clardy; Rong Wang; Dennis Selkoe; Christopher B Eckman
Journal:  ACS Chem Neurosci       Date:  2012-08-28       Impact factor: 4.418

Review 10.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.